Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo
- PMID: 12626531
- DOI: 10.4049/jimmunol.170.6.2817
Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo
Abstract
Dendritic cells (DCs) loaded in vitro with Ag are used as cellular vaccines to induce Ag-specific immunity. These cells are thought to be responsible for direct stimulation of Ag-specific T cells, which may subsequently mediate immunity. In this study, in transgenic mouse models with targeted MHC class II expression specifically on DCs, we show that the DC vaccine is responsible only for partial CD4(+) T cell activation, but to obtain optimal expansion of T cells in vivo, participation of endogenous (resident) DCs, but not endogenous B cells, is crucial. Transfer of Ag to endogenous DCs seems not to be mediated by simple peptide diffusion, but rather by DC-DC interaction in lymph nodes as demonstrated by histological analysis. In contrast, injection of apoptotic or necrotic DC vaccines does not induce T cell responses, but rather represents an immunological null event, which argues that viability of DC vaccines can be crucial for initial triggering of T cells. We propose that viable DCs from the DC vaccine must migrate to the draining lymph nodes and initiate a T cell response, which thereafter requires endogenous DCs that present transferred Ag in order induce optimal T cell expansion. These results are of specific importance with regard to the applicability of DC vaccinations in tumor patients, where the function of endogenous DCs is suppressed by either tumors or chemotherapy.
Similar articles
-
Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model.J Immunol. 2000 Mar 15;164(6):2937-46. doi: 10.4049/jimmunol.164.6.2937. J Immunol. 2000. PMID: 10706680
-
Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.J Immunol. 2006 Feb 1;176(3):1447-55. doi: 10.4049/jimmunol.176.3.1447. J Immunol. 2006. PMID: 16424172
-
Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.J Immunol. 2005 Feb 1;174(3):1274-80. doi: 10.4049/jimmunol.174.3.1274. J Immunol. 2005. PMID: 15661883
-
DCs as targets for vaccine design.Cytotherapy. 2004;6(2):88-98. doi: 10.1080/14653240410005276. Cytotherapy. 2004. PMID: 15203984 Review.
-
Studying interactions between dendritic cells and T cells in vivo.Curr Opin Immunol. 2019 Jun;58:24-30. doi: 10.1016/j.coi.2019.02.002. Epub 2019 Mar 15. Curr Opin Immunol. 2019. PMID: 30884422 Free PMC article. Review.
Cited by
-
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations.Cells. 2023 Aug 25;12(17):2147. doi: 10.3390/cells12172147. Cells. 2023. PMID: 37681880 Free PMC article. Review.
-
Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells.Immunity. 2008 Nov 14;29(5):795-806. doi: 10.1016/j.immuni.2008.08.013. Epub 2008 Oct 23. Immunity. 2008. PMID: 18951047 Free PMC article.
-
In Vivo Modulation of Dendritic Cells by Engineered Materials: Towards New Cancer Vaccines.Nano Today. 2011 Oct;6(5):466-477. doi: 10.1016/j.nantod.2011.08.005. Nano Today. 2011. PMID: 22125572 Free PMC article.
-
Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.Front Immunol. 2021 May 13;12:643255. doi: 10.3389/fimmu.2021.643255. eCollection 2021. Front Immunol. 2021. PMID: 34054810 Free PMC article. Review.
-
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.Front Immunol. 2015 May 20;6:243. doi: 10.3389/fimmu.2015.00243. eCollection 2015. Front Immunol. 2015. PMID: 26042126 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials